The research progress of asthma and chronic obstructive pulmonary disease overlap syndromeLU Ming, YAO Wan-zhen379-381
Clinical significance of airway mucus hypersecretion in chronic obstructive pulmonary diseaseTIAN Pan-wen, WEN Fu-qiang382-385
The personalized choice of phosphodiesterase 4 inhibitor in patients with chronic obstructive pulmonary diseaseZHENG Jin-ping386-388
Identification of infection as the cause of acute exacerbation of chronic obstructive pulmonary disease: A step towards personalized treatmentSUN Yong-chang389-391
Selection of bronchodilator long-acting beta 2 receptor agonists and long-acting muscarinic receptor antagonists in management of chronic obstructive pulmonary disease:Randomly or purposefullyCHEN Ping, ZHAO Hai-tao392-394
Current status and inspiration on macrolides in the therapy of chronic obstructive pulmonary diseaseQIU Shi-lin, ZHONG Xiao-ning395-398
Benefit of inhaled corticosteroids in the treatment of different types of chronic obstructive pulmonary diseaseZHANG Cheng, Zhang Xiang-yan399-401,413
Interpretations of guidelines on diagnosis and trewatment of diffuse large B-cell lymphoma from American National Comprehensive Cancer NetworkGONG Zi-mu, YANG Wei406-410
Interpretations of 2014 NICE guidelines on diagnosis and management of adult community and hostpital acquired pneumoniaJIAO Yang, HUANG Yi411-413
